Amryt Pharma (AMYT.L) stock price, revenue, and financials

Amryt Pharma market cap is £40.4 m, and annual revenue was £12.89 m in FY 2018

£40.4 M

AMYT.L Mkt cap, 31-Oct-2017

£12.9 M

Amryt Pharma Revenue FY, 2018
Amryt Pharma Gross profit (FY, 2018)8.2 M
Amryt Pharma Gross profit margin (FY, 2018), %63.3%
Amryt Pharma Net income (FY, 2018)-23 M
Amryt Pharma EBIT (FY, 2018)-13.6 M
Amryt Pharma Cash, 31-Dec-20188.7 M
Amryt Pharma EV83.3 M

Amryt Pharma Revenue

Amryt Pharma revenue was £12.89 m in FY, 2018

Embed Graph

Amryt Pharma Income Statement

Annual

GBPFY, 2016FY, 2017FY, 2018

Revenue

1.2m11.4m12.9m

Cost of goods sold

522.1k4.8m4.7m

Gross profit

681.6k6.6m8.2m

Gross profit Margin, %

57%58%63%

Depreciation and amortization

171.1k35.7k21.4k

EBIT

(6.8m)(12.7m)(13.6m)

EBIT margin, %

(569%)(111%)(106%)

Interest expense

1.8k751.5k1.2m

Interest income

890.04.5k4.5k

Pre tax profit

(7.0m)(23.3m)(22.9m)

Income tax expense

32.1k

Net Income

(7.0m)(23.3m)(23.0m)

Amryt Pharma Balance Sheet

Annual

GBPFY, 2015FY, 2016FY, 2017FY, 2018

Cash

12.5m7.4m18.3m8.7m

Accounts Receivable

752.0k2.6m2.8m

Inventories

686.0k965.5k1.7m

Current Assets

12.6m10.3m23.5m15.0m

PP&E

5.7k1.1m1.0m855.8k

Total Assets

12.6m58.2m71.4m63.0m

Accounts Payable

188.9k1.7m4.2m4.2m

Current Liabilities

375.3k3.2m8.7m9.4m

Long-term debt

20.8m38.4m51.7m

Non-Current Liabilities

25.6m43.2m56.5m

Total Debt

20.8m38.4m51.7m

Total Liabilities

375.3k28.7m51.9m65.9m

Common Stock

15.1m18.2m18.9m18.9m

Retained Earnings

(33.3m)(8.0m)(31.3m)(54.3m)

Total Equity

12.2m29.4m19.5m(2.9m)

Financial Leverage

1 x2 x3.7 x-21.9 x

Amryt Pharma Cash Flow

Annual

GBPFY, 2015FY, 2016FY, 2017FY, 2018

Cash From Operating Activities

(2.8m)(5.4m)(10.6m)(11.6m)

Cash From Investing Activities

2.3m2.2m(281.7k)(189.0k)

Cash From Financing Activities

10.5m21.7m2.5m

Net Change in Cash

(477.1k)7.2m10.8m(9.4m)

Amryt Pharma Ratios

GBPY, 2018

EV/EBIT

-6.1 x

EV/CFO

-7.2 x

Financial Leverage

-21.9 x